Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Feng Zhang, Rujia Zhong, Cheng Cheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 9, pp. 1382-1389
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation
Jiejian Kou, Jun-Zhuo Shi, Yangyang He, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 840-849
Open Access | Times Cited: 116
Reimagining cholinergic therapy for Alzheimer’s disease
Ezio Giacobini, A. Claudio Cuello, Abraham Fisher
Brain (2022) Vol. 145, Iss. 7, pp. 2250-2275
Open Access | Times Cited: 104
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants
Feng Jin, Youle Zheng, Mingyue Guo, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 3988-4024
Open Access | Times Cited: 60
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 26
Tau Oligomers Neurotoxicity
Grażyna Niewiadomska, Wiktor Niewiadomski, Marta Steczkowska, et al.
Life (2021) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 90
Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer’s disease via inhibition of ACSL4-dependent ferroptosis
Zhiyun Zhu, Yandong Liu, Yan Gong, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 1, pp. 39-49
Open Access | Times Cited: 81
Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
Pradeep K. Shukla, David Delotterie, Jianfeng Xiao, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 779-779
Open Access | Times Cited: 75
The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer’s Disease Mechanism Determined by a Network Pharmacology Approach
Peng Zeng, Xiaoming Wang, Chao‐Yuan Ye, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3612-3612
Open Access | Times Cited: 63
Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside
Fahadul Islam, Mohamed H. Nafady, Md. Rezaul Islam, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4384-4404
Closed Access | Times Cited: 56
Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications
Bin‐Can Tang, Ya‐Ting Wang, Jie Ren
Ibrain (2023) Vol. 9, Iss. 3, pp. 340-348
Open Access | Times Cited: 37
Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer’s disease models
Xinjie Guan, Zhi-qiang Deng, Jia Liu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 900-913
Closed Access | Times Cited: 12
Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease
Rongrong Lin, Lulu Jin, Yan‐Yan Xue, et al.
Advanced Science (2024) Vol. 11, Iss. 24
Open Access | Times Cited: 11
Modulation of the Circadian Rhythm and Oxidative Stress as Molecular Targets to Improve Vascular Dementia: A Pharmacological Perspective
Walter Ángel Trujillo-Rangel, Sofía Acuña-Vaca, Danna Jocelyn Padilla-Ponce, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4401-4401
Open Access | Times Cited: 8
The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Gilbert Ogunmokun, Saikat Dewanjee, Pratik Chakraborty, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2790-2790
Open Access | Times Cited: 52
Does Inflammation Play a Major Role in the Pathogenesis of Alzheimer's Disease?
Benita Wiatrak, Paulina Jawień, Adam Szeląg, et al.
NeuroMolecular Medicine (2023) Vol. 25, Iss. 3, pp. 330-335
Open Access | Times Cited: 16
Pyroptosis in neurodegenerative diseases: from bench to bedside
Kejia Wu, Wan-rong Wang, Qian-hui Cheng, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2467-2499
Closed Access | Times Cited: 16
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 7
Evolving Role of Natural Products from Traditional Medicinal Herbs in the Treatment of Alzheimer’s Disease
Surya Nath Pandey, Naresh Kumar Rangra, Sima Singh, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 15, pp. 2718-2728
Closed Access | Times Cited: 33
Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects
Saad Alkahtani, Norah S. AL–Johani, Saud Alarifi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1340-1340
Open Access | Times Cited: 14
Therapeutic Inhalation of Hydrogen Gas for Alzheimer’s Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study
Hirohisa Ono, Yoji Nishijima, Shigeo Ohta
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 434-434
Open Access | Times Cited: 13
Clathrin mediated endocytosis in Alzheimer’s disease: cell type specific involvement in amyloid beta pathology
Sierra Jaye, Ursula S Sandau, Julie A. Saugstad
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Oral Administration of Bifidobacterium lactis Ameliorates Cognitive Deficits in Mice Intracerebroventricularly Administered Amyloid Beta via Regulation the Activation of Mitogen-activated Protein Kinases
Jong Kyu Choi, Oh Yun Kwon, Seung Ho Lee
Food Science of Animal Resources (2024) Vol. 44, Iss. 3, pp. 607-619
Open Access | Times Cited: 4
Therapeutic potential of plant-derived natural compounds in Alzheimer’s disease: Targeting microglia-mediated neuroinflammation
Yanyan Shen, Fang Liu, Mingjie Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117235-117235
Closed Access | Times Cited: 4
Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer
Elisabeth Müller, Thomas Enzlein, Dagmar Niemeyer, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 252-252
Open Access
Page 1 - Next Page

Scroll to top